Cancellous Bone Screw
by Dow Corning Wright 510(k)
Active
510(k) K864626
Overview
A cancellous bone screw is an orthopedic device designed for fixation in spongy bone. It is used to stabilize fractures or bone grafts in areas with low bone density, such as the vertebral bodies or metaphyseal regions.
This device is supplied as a reusable or single-use implant depending on the specific model and is intended for use in orthopedic surgical settings. It received FDA 510(k) clearance (K864626) on December 15, 1986, as substantially equivalent to a predicate device, and is classified under product code HWC with Orthopedic advisory committee review.
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK864626 | Date15 Dec 1986 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not known
- Not covered
United States — FDA 510(k) Active
Recalls
No FDA recalls on record, checked 22 Oct 2026.
Specification
- 510(k) Number
- FDA Product Code
- HWC
- Device Class
- Class II
- Regulation
- 21 CFR Part 888.3040
- Advisory Committee
- Orthopedic
- FDA Decision
- SESE Substantially Equivalent
Other devices from Dow Corning Wright
Questions
What is the cancellous bone screw used for?
The cancellous bone screw is designed for fixation in spongy bone to stabilize fractures or bone grafts in areas with low bone density, such as vertebral bodies or metaphyseal regions, based on its intended use in orthopedic surgical settings.
Is the cancellous bone screw reusable or single-use?
The device is supplied as either reusable or single-use depending on the specific model, as indicated in the description, which states it is intended for use in orthopedic surgical settings with variability based on model.
What regulatory pathway was used for the cancellous bone screw?
The device received FDA 510(k) clearance (K864626) on December 15, 1986, as substantially equivalent to a predicate device, following a traditional clearance process with Orthopedic advisory committee review.